soul trial oral semaglutide cardiovascular outcomes 2025 NEJM Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full results at NEJM.org (link in bio). ⁣, ⁣, #ACC25 #Cardiology #ClinicalTrials #NEJM A trial emulation in Nature

It simply means your body may benefit more from pre-methylated forms of folate and B12

Rare but serious side effects: Pancreitis, gallbladder disease, and thyroid tumors are rare but serious potential side effects of taking GLP-1 agonists

Medications, if indicated, can help with weight loss alongside a healthy diet and exercise program

Activation of these receptors may modulate dopamine signaling, potentially reducing alcohol's rewarding properties, though the exact mechanisms in humans remain under investigation

How Semaglutide Supports Weight Management A common recommendation for people with obesity is 5% weight loss

These peptides complement IGF-1 LR3's anabolic effects by supporting the connective tissue and recovery infrastructure that intense training demands